Oryzalin but not Itraconazole disrupts CTP synthase localization in some Toxoplasma gondii tachyzoites

Toxoplasmosis is a worldwide prevalent infection caused by the Toxoplasma gondii parasite, that could lead to several diseases especially in new-borns and immunocompromised patients, therefore, discovery of novel drug targets has become a major concern. The pyrimidine pathway has been proposed as a...

Full description

Autores:
Gutiérrez Melo, Nicolás
Tipo de recurso:
Trabajo de grado de pregrado
Fecha de publicación:
2017
Institución:
Universidad de los Andes
Repositorio:
Séneca: repositorio Uniandes
Idioma:
eng
OAI Identifier:
oai:repositorio.uniandes.edu.co:1992/61471
Acceso en línea:
http://hdl.handle.net/1992/61471
Palabra clave:
Enzimas
Interacciones proteína-proteína
Parasitología
Toxoplasma gondii
Rights
openAccess
License
http://creativecommons.org/licenses/by-nc-sa/4.0/
id UNIANDES2_eaab29676ed32db37090b5743da5d3c6
oai_identifier_str oai:repositorio.uniandes.edu.co:1992/61471
network_acronym_str UNIANDES2
network_name_str Séneca: repositorio Uniandes
repository_id_str
dc.title.spa.fl_str_mv Oryzalin but not Itraconazole disrupts CTP synthase localization in some Toxoplasma gondii tachyzoites
title Oryzalin but not Itraconazole disrupts CTP synthase localization in some Toxoplasma gondii tachyzoites
spellingShingle Oryzalin but not Itraconazole disrupts CTP synthase localization in some Toxoplasma gondii tachyzoites
Enzimas
Interacciones proteína-proteína
Parasitología
Toxoplasma gondii
title_short Oryzalin but not Itraconazole disrupts CTP synthase localization in some Toxoplasma gondii tachyzoites
title_full Oryzalin but not Itraconazole disrupts CTP synthase localization in some Toxoplasma gondii tachyzoites
title_fullStr Oryzalin but not Itraconazole disrupts CTP synthase localization in some Toxoplasma gondii tachyzoites
title_full_unstemmed Oryzalin but not Itraconazole disrupts CTP synthase localization in some Toxoplasma gondii tachyzoites
title_sort Oryzalin but not Itraconazole disrupts CTP synthase localization in some Toxoplasma gondii tachyzoites
dc.creator.fl_str_mv Gutiérrez Melo, Nicolás
dc.contributor.advisor.none.fl_str_mv Zimmermann, Barbara Hanna
dc.contributor.author.none.fl_str_mv Gutiérrez Melo, Nicolás
dc.subject.keyword.spa.fl_str_mv Enzimas
Interacciones proteína-proteína
Parasitología
Toxoplasma gondii
topic Enzimas
Interacciones proteína-proteína
Parasitología
Toxoplasma gondii
description Toxoplasmosis is a worldwide prevalent infection caused by the Toxoplasma gondii parasite, that could lead to several diseases especially in new-borns and immunocompromised patients, therefore, discovery of novel drug targets has become a major concern. The pyrimidine pathway has been proposed as a possible drug target, since apicomplexan enzymes vary from those of humans. Previous studies have shown that inhibition of CTP synthase with the glutamine antagonist 6-diazo-5-oxo-L-norleucine (DON), disrupts tachyzoites' morphology and reduces significantly the infection progression. A similar phenomenon has been described with inhibitors such as oryzalin and itraconazole but the exact mechanism has not been clearly elucidated yet. Consequently, the aim of this study was to determine if CTP synthase is affected by the inhibition effect during treatment with oryzalin and itraconazole. T. gondii tachyzoites were cultured in HFF cells and treated with 2 uM Itraconazole, 0.5 and 2.5 uM oryzalin, or 30 uM DON, or with combinations of inhibitors. Infected host cells were fixed 28 hours post infection and CTP synthase localization was assessed using immunofluorescence. Parasites treated with itraconazole alone or in combination with DON did not display any significant differences in enzyme localization compared to those observed in control treatments. However, incubation with oryzalin appeared to affect CTP synthase distribution since protein aggregates tended to localize towards the sides of some of the tachyzoites. These results suggest that CTP synthase might be involved in parasite morphology but stronger evidence is needed.
publishDate 2017
dc.date.issued.spa.fl_str_mv 2017
dc.date.accessioned.none.fl_str_mv 2022-09-26T22:22:05Z
dc.date.available.none.fl_str_mv 2022-09-26T22:22:05Z
dc.type.spa.fl_str_mv Trabajo de grado - Pregrado
dc.type.driver.spa.fl_str_mv info:eu-repo/semantics/bachelorThesis
dc.type.version.spa.fl_str_mv info:eu-repo/semantics/acceptedVersion
dc.type.coar.spa.fl_str_mv http://purl.org/coar/resource_type/c_7a1f
dc.type.content.spa.fl_str_mv Text
dc.type.redcol.spa.fl_str_mv http://purl.org/redcol/resource_type/TP
format http://purl.org/coar/resource_type/c_7a1f
status_str acceptedVersion
dc.identifier.uri.none.fl_str_mv http://hdl.handle.net/1992/61471
dc.identifier.instname.spa.fl_str_mv instname:Universidad de los Andes
dc.identifier.reponame.spa.fl_str_mv reponame:Repositorio Institucional Séneca
dc.identifier.repourl.spa.fl_str_mv repourl:https://repositorio.uniandes.edu.co/
dc.identifier.local.spa.fl_str_mv 795170-1001
url http://hdl.handle.net/1992/61471
identifier_str_mv instname:Universidad de los Andes
reponame:Repositorio Institucional Séneca
repourl:https://repositorio.uniandes.edu.co/
795170-1001
dc.language.iso.spa.fl_str_mv eng
language eng
dc.rights.uri.*.fl_str_mv http://creativecommons.org/licenses/by-nc-sa/4.0/
dc.rights.accessrights.spa.fl_str_mv info:eu-repo/semantics/openAccess
dc.rights.coar.spa.fl_str_mv http://purl.org/coar/access_right/c_abf2
rights_invalid_str_mv http://creativecommons.org/licenses/by-nc-sa/4.0/
http://purl.org/coar/access_right/c_abf2
eu_rights_str_mv openAccess
dc.format.extent.spa.fl_str_mv 14 hojas
dc.format.mimetype.spa.fl_str_mv application/pdf
dc.publisher.spa.fl_str_mv Universidad de los Andes
dc.publisher.program.spa.fl_str_mv Microbiología
dc.publisher.faculty.spa.fl_str_mv Facultad de Ciencias
dc.publisher.department.spa.fl_str_mv Departamento de Ciencias Biológicas
institution Universidad de los Andes
bitstream.url.fl_str_mv https://repositorio.uniandes.edu.co/bitstreams/f3e40c15-ade9-4db2-b2fe-0169578c1391/download
https://repositorio.uniandes.edu.co/bitstreams/f78891b4-70c3-487a-aee2-25187da52f52/download
https://repositorio.uniandes.edu.co/bitstreams/cbea6748-e6c8-4f98-8077-a21716caec7c/download
bitstream.checksum.fl_str_mv a3443dd6b32a2811cd9c5f17f0136345
1d2216c5154934bcd1f3f7fec97d317a
a9aead91c806bcfe5c05f5bf24dbf900
bitstream.checksumAlgorithm.fl_str_mv MD5
MD5
MD5
repository.name.fl_str_mv Repositorio institucional Séneca
repository.mail.fl_str_mv adminrepositorio@uniandes.edu.co
_version_ 1812133834982948864
spelling Al consultar y hacer uso de este recurso, está aceptando las condiciones de uso establecidas por los autores.http://creativecommons.org/licenses/by-nc-sa/4.0/info:eu-repo/semantics/openAccesshttp://purl.org/coar/access_right/c_abf2Zimmermann, Barbara Hanna81271423-588b-479b-a844-0d7443608a49500Gutiérrez Melo, Nicolás56425af1-2ff9-44a3-a208-702a35c15b185002022-09-26T22:22:05Z2022-09-26T22:22:05Z2017http://hdl.handle.net/1992/61471instname:Universidad de los Andesreponame:Repositorio Institucional Sénecarepourl:https://repositorio.uniandes.edu.co/795170-1001Toxoplasmosis is a worldwide prevalent infection caused by the Toxoplasma gondii parasite, that could lead to several diseases especially in new-borns and immunocompromised patients, therefore, discovery of novel drug targets has become a major concern. The pyrimidine pathway has been proposed as a possible drug target, since apicomplexan enzymes vary from those of humans. Previous studies have shown that inhibition of CTP synthase with the glutamine antagonist 6-diazo-5-oxo-L-norleucine (DON), disrupts tachyzoites' morphology and reduces significantly the infection progression. A similar phenomenon has been described with inhibitors such as oryzalin and itraconazole but the exact mechanism has not been clearly elucidated yet. Consequently, the aim of this study was to determine if CTP synthase is affected by the inhibition effect during treatment with oryzalin and itraconazole. T. gondii tachyzoites were cultured in HFF cells and treated with 2 uM Itraconazole, 0.5 and 2.5 uM oryzalin, or 30 uM DON, or with combinations of inhibitors. Infected host cells were fixed 28 hours post infection and CTP synthase localization was assessed using immunofluorescence. Parasites treated with itraconazole alone or in combination with DON did not display any significant differences in enzyme localization compared to those observed in control treatments. However, incubation with oryzalin appeared to affect CTP synthase distribution since protein aggregates tended to localize towards the sides of some of the tachyzoites. These results suggest that CTP synthase might be involved in parasite morphology but stronger evidence is needed.La toxoplasmosis es una infección prevalente en todo el mundo causada por el parásito Toxoplasma gondii y que puede conducir a varias enfermedades especialmente en recién nacidos y pacientes inmunocomprometidos, razón por la cual, el descubrimiento de nuevos blancos terapéuticos se ha convertido en una preocupación importante. La vía de síntesis de las pirimidinas se ha propuesto como un posible objetivo de fármaco, ya que las enzimas del filo apicomplexa difieren significativamente de las de los seres humanos. Estudios previos han demostrado que la inhibición de la CTP sintasa con el antagonista de la glutamina 6-diazo-5-oxo-L-norleucina (DON), altera la morfología de los taquizoítos y reduce radicalmente la progresión de la infección. Un fenómeno similar se ha descrito con inhibidores tales como oryzalin e itraconazol pero el mecanismo exacto de aún no se conoce con claridad. En consecuencia, el objetivo de este estudio fue determinar si la CTP sintasa se ve afectada por la inhibición durante el tratamiento con oryzalin e itraconazol. Los taquizoitos de T. gondii se cultivaron en células HFF y se trataron con itraconazol 2 uM, oryzalin 0,5 y 2,5 uM o DON 30 uM, o con combinaciones de inhibidores. Las células huésped infectadas se fijaron 28 horas post infección y la localización de CTP sintasa se evaluó utilizando inmunofluorescencia. Los parásitos tratados con itraconazol solo o en combinación con DON no mostraron diferencias significativas en la localización enzimática en comparación con los observados en el tratamiento control. Sin embargo, la incubación con oryzalin parece afectar la distribución de la CTP sintasa, ya que los agregados de proteínas tienden a desplazarse hacia los lados en algunos taquizoitos. Estos resultados sugieren que la CTP sintasa podría estar involucrada en la morfología del parásito, no obstante, mayor evidencia es necesaria para soportarlo.--Tomado del Formato de Documento de Grado.MicrobiólogoPregrado14 hojasapplication/pdfengUniversidad de los AndesMicrobiologíaFacultad de CienciasDepartamento de Ciencias BiológicasOryzalin but not Itraconazole disrupts CTP synthase localization in some Toxoplasma gondii tachyzoitesTrabajo de grado - Pregradoinfo:eu-repo/semantics/bachelorThesisinfo:eu-repo/semantics/acceptedVersionhttp://purl.org/coar/resource_type/c_7a1fTexthttp://purl.org/redcol/resource_type/TPEnzimasInteracciones proteína-proteínaParasitologíaToxoplasma gondii201224433PublicationTEXT12954.pdf.txt12954.pdf.txtExtracted texttext/plain25785https://repositorio.uniandes.edu.co/bitstreams/f3e40c15-ade9-4db2-b2fe-0169578c1391/downloada3443dd6b32a2811cd9c5f17f0136345MD52THUMBNAIL12954.pdf.jpg12954.pdf.jpgIM Thumbnailimage/jpeg20488https://repositorio.uniandes.edu.co/bitstreams/f78891b4-70c3-487a-aee2-25187da52f52/download1d2216c5154934bcd1f3f7fec97d317aMD53ORIGINAL12954.pdfapplication/pdf344963https://repositorio.uniandes.edu.co/bitstreams/cbea6748-e6c8-4f98-8077-a21716caec7c/downloada9aead91c806bcfe5c05f5bf24dbf900MD511992/61471oai:repositorio.uniandes.edu.co:1992/614712023-10-10 15:46:24.604http://creativecommons.org/licenses/by-nc-sa/4.0/open.accesshttps://repositorio.uniandes.edu.coRepositorio institucional Sénecaadminrepositorio@uniandes.edu.co